Hoo Gargle (jasmine flavor) (mouthwash)

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available text.

Uses and Indications

This drug is indicated for use in specific patient populations as determined by clinical guidelines. Currently, there are no detailed indications or usage specifications provided. Healthcare professionals are advised to refer to the latest clinical data and guidelines to determine appropriate applications for this drug. There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The product is indicated for dental use only. Healthcare professionals should ensure that the administration is confined to the dental setting to maintain safety and efficacy. Proper techniques and protocols should be followed during the preparation and application to achieve optimal results.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

Healthcare professionals should advise patients to exercise caution during the use of this product. It is imperative that patients avoid swallowing the product. Following application, patients should rinse their mouths thoroughly to mitigate any potential adverse effects associated with ingestion.

In addition, healthcare providers should monitor patients for any signs of irritation or adverse reactions following use. Regular assessment of oral health may be warranted to ensure that the product is not contributing to any negative outcomes.

Side Effects

Patients should be advised to exercise caution during use, specifically to avoid swallowing the product. It is also important for patients to rinse their mouths thoroughly after use to mitigate any potential adverse effects. Currently, there are no reported common, less common, or rare adverse reactions associated with this product, nor are there any documented serious side effects, allergic reactions, or cardiovascular or neurological issues. Additionally, no adverse reactions have been noted in postmarketing experiences.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Hoo Gargle (jasmine flavor) (mouthwash) (sodium flouride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the product out of reach of children to prevent accidental ingestion. Care should be taken to avoid swallowing the product, and it is recommended that the mouth be rinsed thoroughly after use to ensure safety and minimize any potential adverse effects.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for HOO GARGLE (JASMINE FLAVOR)(MOUTHWASH). Therefore, the effects on breastfed infants and the excretion of the drug in breast milk remain undetermined. Healthcare professionals should exercise caution and consider the potential risks and benefits when recommending this product to lactating mothers.

Renal Impairment

Patients with renal impairment may necessitate dosage adjustments to ensure safety and efficacy. It is important to monitor renal function tests regularly in these patients to assess their kidney status. Additionally, a reduced dose should be considered for patients with decreased creatinine clearance to mitigate the risk of adverse effects associated with impaired renal function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and consider general principles of management for suspected cases of drug overdosage.

Recommended Actions In the event of an overdosage, it is essential to assess the patient's clinical status promptly. Healthcare providers should initiate supportive care and monitor vital signs closely. The management of overdosage may include the following steps:

1. Assessment: Evaluate the patient's symptoms and history of exposure to the drug.

2. Supportive Care: Provide symptomatic treatment as necessary, which may include intravenous fluids, oxygen supplementation, or other interventions based on the patient's condition.

3. Consultation: Engage with a poison control center or a medical toxicologist for guidance on specific management strategies tailored to the drug involved.

Potential Symptoms While specific symptoms of overdosage are not detailed, healthcare professionals should remain vigilant for signs of toxicity that may arise from excessive dosing of medications. Symptoms can vary widely depending on the pharmacological properties of the drug and may include, but are not limited to, neurological, cardiovascular, or gastrointestinal manifestations.

In summary, due to the lack of specific overdosage information, healthcare professionals should rely on established protocols for managing suspected overdosage cases, ensuring that patient safety remains the top priority.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of storing the medication in a secure location, ensuring that children cannot access it. This precaution helps to safeguard the health and safety of young individuals in the household.

Storage and Handling

The product is supplied in configurations suitable for dental use only. It is essential to keep the product out of reach of children to ensure safety.

Storage conditions should be carefully observed to maintain product integrity. Specific temperature ranges and container requirements are not provided; however, standard practices for dental products should be followed. Special handling needs may apply, and it is advisable to consult relevant guidelines to ensure proper management of the product.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients to be cautious not to swallow the medication and to rinse their mouths thoroughly after use. There is no additional information available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Hoo Gargle (jasmine flavor) (mouthwash), including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)